​

Replimune Group Ownership | Who Owns Replimune Group?


OverviewForecastFinancialsChartTranscripts

Replimune Group Ownership Summary


Replimune Group is owned by 109.46% institutional investors, 1.63% insiders. Baker bros. advisors lp is the largest institutional shareholder, holding 11.90% of REPL shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 2.82% of its assets in Replimune Group shares.

REPL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockReplimune Group109.46%1.63%-11.09%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp11.05M11.90%$122.27M
Blackrock funding, inc. /de8.80M9.08%$116.50M
Rtw investments, lp7.41M7.99%$82.05M
Ridgeback capital investments7.31M7.88%$80.93M
Blackrock4.71M7.08%$42.42M
Goldman sachs group4.54M4.89%$50.27M
Suvretta capital management4.39M4.73%$48.60M
State street4.17M4.31%$55.27M
Boxer capital management3.98M4.29%$44.09M
Vanguard group3.78M4.10%$36.70M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ridgeback capital investments7.31M100.00%$80.93M
Fcpm iii services b.v.2.81M4.14%$31.09M
Boxer capital management3.98M3.32%$44.09M
Eagle health investments lp724.79K1.58%$9.60M
Opaleye management1.38M1.39%$15.33M
Ghost tree capital450.00K1.27%$4.05M
Logos global management lp2.50M1.19%$27.68M
Sofinnova investments1.81M1.03%$16.78M
Suvretta capital management4.39M0.89%$48.60M
Emerald mutual fund advisers trust1.60M0.87%$21.23M

Top Buyers

HolderShares% AssetsChange
Ridgeback capital investments7.31M100.00%7.31M
Marshall wace, llp3.82M0.04%3.82M
Boxer capital management3.98M3.32%2.81M
Logos global management lp2.50M1.19%2.50M
Braidwell lp2.75M0.34%2.33M

Top Sellers

HolderShares% AssetsChange
Price t rowe associates inc /md/1.62M0.00%-6.50M
Atlas venture life science advisors---2.10M
Jane street group761.84K0.00%-1.56M
Commodore capital lp---1.43M
Rosalind advisors---1.41M

New Positions

HolderShares% AssetsChangeValue
Ridgeback capital investments7.31M100.00%7.31M$80.93M
Marshall wace, llp3.82M0.04%3.82M$50.52M
Logos global management lp2.50M1.19%2.50M$27.68M
Emerald advisers2.04M0.74%2.04M$27.03M
Eventide asset management1.69M0.31%1.69M$22.38M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-8.00
Global retirement partners-32.00
Creative financial designs inc /adv-33.00
Stephens consulting-35.00
Td private client wealth-48.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026225-0.44%106,025,49110.35%1091.11%118-20.81%6340.00%
Jun 30, 20262258.70%96,084,26018.48%1031.34%14733.64%46-16.36%
Mar 31, 202665-64.67%10,497,436-86.84%110.15%32-65.59%18-67.86%
Dec 31, 2025102-46.32%28,686,776-65.39%310.38%51-52.34%33-31.25%
Sep 30, 20251873.89%82,873,9546.75%901.26%10525.00%48-20.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
State Street® SPDR® S&P® Biotech ETF2.67M2.82%69.86K
Vanguard US Total Market Shares ETF2.02M2.63%478.00K
Vanguard MStar Total Stk Mkt Idx Invest2.42M2.57%444.70K
Vanguard Total Stock Mkt Idx Inv1.97M2.35%-
Vanguard Morn Total Stk Mkt Idx Investor1.97M2.35%-
iShares Russell 2000 ETF2.06M2.17%-
T. Rowe Price Integrated US SmCapGrEq1.60M1.94%-
T. Rowe Price Health Sciences1.43M1.73%-91.78K
Artisan International Small-Mid Investor1.57M1.67%965.54K
T. Rowe Price New Horizons Tr-Z1.28M1.66%1.80K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 09, 2026SLATTERY JOSEPH P-Sell$113.36K
Nov 02, 2026Dhingra Kapil-Sell$408.50K
Aug 17, 2026Hill Emily Luisa Chief Financial OfficerSell$132.18K
Aug 10, 2026Patel Sushil Chief Executive OfficerSell$510.25K
Aug 10, 2026Hill Emily Luisa Chief Financial OfficerSell$148.48K

Insider Transactions Trends


DateBuySell
2026 Q4-2
2026 Q325
2026 Q2-8
2026 Q1--
2025 Q4-4

REPL Ownership FAQ


Who Owns Replimune Group?

Replimune Group shareholders are primarily institutional investors at 109.46%, followed by 1.63% insiders and -11.09% retail investors. The average institutional ownership in Replimune Group's industry, Biotech Stocks , is 181.71%, which Replimune Group falls below.

Who owns the most shares of Replimune Group?

Replimune Group’s largest shareholders are Baker bros. advisors lp (11.05M shares, 11.90%), Blackrock funding, inc. /de (8.8M shares, 9.08%), and Rtw investments, lp (7.41M shares, 7.99%). Together, they hold 28.97% of Replimune Group’s total shares outstanding.

Does Blackrock own Replimune Group?

Yes, BlackRock owns 7.08% of Replimune Group, totaling 4.71M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.42M$. In the last quarter, BlackRock increased its holdings by 101.23K shares, a 2.19% change.

Who is Replimune Group’s biggest shareholder by percentage of total assets invested?

Ridgeback capital investments is Replimune Group’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 7.31M Replimune Group shares, valued at 80.93M$.

Who is the top mutual fund holder of Replimune Group shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Replimune Group shares, with 2.82% of its total shares outstanding invested in 2.67M Replimune Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools